SPIRONOLACTONE | N209478 | CMP DEVELOPMENT LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2021-04-16 | Terminated 2023-10-11 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.45
per ml
Lowest NADAC/Unit
$1.81
per ml
Brand NDCs
1
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 46287002004CAROSPIR 25 MG/5 ML SUSPENSION | $3.45 | ML | Brand | $1.81 | 2026-09-23 |
| 00574113316SPIRONOLACTONE 25 MG/5 ML SUSP | $1.89 | ML | Generic | — | 2026-10-21 |
| 00574113304SPIRONOLACTONE 25 MG/5 ML SUSP | $1.81 | ML | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9757394 | Oct 28, 2036 | — | — | Yes | — | |
| 10493083 | Oct 28, 2036 | — | — | Yes | — | — |
| 10624906 | Oct 28, 2036 | — | — | Yes | — | — |
| 10660907 | Oct 28, 2036 | — | — | Yes | — | — |
| 10888570 | Oct 28, 2036 | — | — | Yes | — | — |
| 11389461 | Oct 28, 2036 | — | — | Yes | — | — |
| 11395828 | Oct 28, 2036 | — | — | — | — | |
| 11395828 | Oct 28, 2036 | — | — | — | — | |
| 11395828 | Oct 28, 2036 | — | — | — | — | |
| 11491166 | Oct 28, 2036 | — | — | Yes | — | — |